Participants who correctly answered that the PSA test was a blood test to screen for prostate cancer were more likely to self-report that they have had a PSA test (p < 0.0001, OR = 5.06, 95% CI [2.38, 10.73]) than their counterparts. The gene discussed is KLK3; the disease is prostate carcinoma.